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Abstract
Background: Stem cells are capable of unlimited self-renewal and are able to remain undifferentiated for extended
periods of time prior to their differentiation into specific cell lineages. Because of the issues (ethical and religious)
involved in the use of embryonic stem cells and the limited plasticity of adult stem cells, an alternative cell source
could be foetal stem cells derived from extra-embryonic tissue, which are highly proliferative, grow in vitro and
possess interesting immunogenic characteristics. As a result, the amniotic membrane of several species has been
studied as an important new source of stem cells.
Methods: Here, we cultured and characterized mesenchymal progenitor cells derived from the rabbit amniotic
membrane, and investigated their differentiation potential. In total, amniotic membranes were collected from eight
rabbit foetuses and were isolated by the explant technique. The obtained cells were cultured in DMEM-HIGH
glucose and incubated at 37 °C in a humidified atmosphere with 5% CO2.
Results: The cells adhered to the culture plates and showed a high proliferative capacity with fibroblast-like
morphologies. The cells showed a positive response for markers for the cytoskeleton, mesenchymal stem cells
and proliferation, pluripotency and haematopoietic precursor stem cells. However, the cells were negative for
CD45, a marker of haematopoietic cells. Furthermore, the cells had the capacity to be induced to differentiate
into osteogenic, adipogenic and chondrogenic lineages. In addition, when the cells were injected into nude mice,
we did not observe the formation of tumours.
Conclusions: In summary, our results demonstrate that multipotent mesenchymal stem cells can be obtained from
the rabbit amniotic membrane for possible use in future cell therapy applications.
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Background
In recent years, there has been growing interest in
obtaining stem cells derived from extra-embryonic tis-
sues because they possess considerable expansion and
proliferative capacities in vitro, which favours the estab-
lishment of cell line banks. In addition, those human tis-
sues are routinely discarded after birth, and their use does
not involve significant ethical or religious problems [1–3].
Stem cells derived from foetal membranes and placental
tissues maintain the characteristics of embryonic tissues,
including the expression of markers associated with
embryonic stem cells, such as Oct-4 and Nanog, and a
high proliferative capacity in vitro [4–6] without the risk
of tumourigenesis [7, 8]. This is in contrast to embryonic
cells, where histocompatibility problems increase the
potential for tumourigenicity [1] and there are ethical
considerations involved in their use.
The amniotic membrane in particular has been the
focus for researchers [9, 10]. The membrane arises early
from amnioblasts derived from the epiblast, which could
favour the potential for high pluripotency, as has been
confirmed by the expression of markers such as Sox-2,
Nanog, Oct-4 and Rex-1 [11, 12]. However, the potential
applications of amniotic membrane cells are not due
only to their pluripotency but also to their immunogenic
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characteristics [13, 14]. Various transplant studies and
grafts performed using human amniotic membrane-
derived cells have shown a lack of an immune response
[15–17], which could be explained by the immunomodu-
lating properties of foetal membranes that are involved in
maintenance of maternal–foetal tolerance [10]. Another
important factor is that these cells show major histocom-
patibility complex (MHC) class I but not MHC class II
expression [16, 18, 19]. Because of these characteristics,
the amniotic membrane has emerged as an important
new source of stem cells in different species including
human [20–22], horse [11, 23, 24], sheep [25], cat [7, 26],
dog [3, 5] and mouse [27] (Table 1).
Parolini et al. [10], in their studies of the human amni-
otic membrane, reported two cell types: epithelial cells de-
rived from the ectoderm; and mesenchymal cells derived
from the mesoderm. The epithelial cells derived from the
amniotic membrane were isolated by the manual separ-
ation of the amnion from the chorion followed by trypsin
digestion. In culture, these cells express epithelial markers
such as cytokeratin [12], the embryonic cell markers
SSEA-4 and TRA-1-60, and the pluripotency markers
Oct-4, Sox-2 and Nanog, but do not express mesenchymal
markers [19, 28]. Moreover, mesenchymal cells were
isolated from the amniotic membrane by the mechanical
separation of the amnion and the chorion followed by
digestion with collagenase [10]. In culture, these cells
express mesenchymal markers such as CD73, CD90 and
CD105, but do not express the haematopoietic cell
markers CD34 and CD45 [7, 17, 29, 30].
In humans, limitations regarding the collection of am-
niotic membranes (e.g. their availability only at delivery,
except in some abortion cases) could restrict our ability
to study the true potential of this tissue to be a source of
stem cells. In this regard, the use of animal models is es-
sential to further our understanding of the plasticity of
this membrane. In addition, the characterization of new
species as experimental models is of fundamental im-
portance because experimental research and preclinical
testing are prerequisites for further clinical use and as
such are extremely relevant in human medicine [31]. In
this context, rabbits have served as important experimen-
tal models due to their advantages related to behaviour,
low maintenance costs and short period of pregnancy
(32 days) [32, 33]. Moreover, rabbits are more phylogenet-
ically similar to primates than are rodents and possess a
more diverse genetic background, making them more suit-
able for use as experimental models [34].
Considering the advances in veterinary medicine in the
last years, as well as the perspectives of an applied transla-
tional medicine, stem cells have an important role in this
context. Because of the problematic aspects related to
obtaining samples of human placental tissues from early
to middle gestation, animal models may solve important
gaps in our knowledge, especially rabbits which share sev-
eral morphological and physiological characteristics with
humans, in addition to the apparent success in obtaining,
culturing and utilizing different lineages of progenitor cells
from rabbit tissues [35–37]. In this way, this study aimed
to isolate, characterize and differentiate progenitor cells
obtained from the rabbit amniotic membrane at 16 days
of gestation.
Methods
Animals
In total, eight rabbit foetuses were used at 16 days of
gestation. The animals were derived from the slaughter-
house of the Faculty of Animal Science and Food Engin-
eering, University of São Paulo, FZEA-USP, which is
located in Pirassununga, SP, Brazil. The project was ap-
proved by the bioethics commission of the School of
Veterinary Medicine and Animal Science-USP (Protocol
number 1891200514).
Isolation, culture and morphological analysis of cells
derived from the amniotic membrane
After their collection, fragments of the amniotic mem-
brane were deposited in Petri dishes (catalogue number
3296; Corning, NY, USA) and were washed five times with
PBS and penicillin–streptomycin 5% in a laminar flow.
Explants from the amniotic membranes were placed in
100-mm diameter culture plates (catalogue number 3296;
Table 1 Cells derived from amniotic membranes
Species Cell types Markers expressed Differentiated lineages References
Human Epithelial and
mesenchymal
CD90, CD44, CD73, CD116, CD117,
CD105, CD29, SSEA-4, STRO-1
Osteogenic, chondrogenic, adipogenic,
myogenic, neurogenic
[10, 20–22, 29, 73]
Cat Epithelial SSEA-4, CD34 Oct-4, Nanog, CD44, CD116 Osteogenic, chondrogenic, adipogenic, neurogenic [7, 26]
Dog Mesenchymal CD90, CD105 Osteogenic, chondrogenic, adipogenic [3, 5]
Horse Mesenchymal CD19, CD20, CD28, CD31, CD38,CD41,
CD44, CD62, CD90, CD105, CD200
Osteogenic, chondrogenic, adipogenic [11, 23, 24, 49]
Sheep Epithelial Oct-4, SSEA-1, SSEA-3, SSEA-4,
TRA-1-60 and TRA-1-81, Nanog
Neurogenic, osteogenic [25, 48, 74]
Mouse Mesenchymal CD90, CD29, Vimentin Osteogenic, adipogenic, neurogenic, hepatogenic [27]
Characteristics related to the morphologies, phenotypes and differentiation potential of stem cells derived from amniotic membranes of different species
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Corning) with 7 ml of culture medium. Three culture
media were tested—DMEM-high glucose (DMEM-HIGH,
catalogue number BR30003-05; LGC Biotecnologia, Cotia,
SP, Brazil), DMEM-F12 (1:1) (catalogue number BR30004-
05; LGC Biotecnologia) and MEM/ALPHA (catalogue
number BR3007-05; LGC Biotecnologia)—and each con-
dition was supplemented with 15% foetal bovine serum
(FBS, catalogue number BR330110-01; LGC Biotecnolo-
gia), 1% streptomycin/penicillin, 1% essential amino acids
(catalogue number BR30238-01; LGC Biotecnologia) and
0.05% sodium pyruvate (catalogue number S8636; Sigma,
St. Louis, MO, USA). Plates were maintained in an incu-
bator at a temperature of 37 °C with a humidified atmos-
phere containing 5% CO2. After culturing for 24 hours,
the first few adherent cells were observed, and the cell
adhesion medium was changed every 48–72 hours. When
cells reached 80% confluence, they were subjected to
trypsinization for expansion. For this, cells were washed
with PBS and then 0.25% trypsin (catalogue number
BR30042-01; LGC Biotecnologia) was added. After 5
minutes at 37 °C, the trypsinization was stopped by
adding the same volume of culture medium. The cells
were then centrifuged for 5 minutes at 1200 rpm.
Morphological analysis of the cells was performed every
3 days using an inverted microscope (Nikon Eclipse TS-
100), and the experiments were performed in passages 4
and 8.
Cryopreservation test
Aliquots of 1 × 106 cells derived from the amniotic
membrane were frozen for the following experiments.
The freezing medium was comprised of 90% FBS and
10% dimethyl sulfoxide (DMSO, catalogue number
13-0091.01; LGC Biotecnologia). The cells were subcul-
tured and resuspended in 1.5 ml freezing medium and
then equally distributed into cryotubes (catalogue
number 430488; Corning). The cryotubes were trans-
ferred to a freezer at −80 °C overnight, and after 24 hours
the cryotubes were transferred to liquid nitrogen. For
experiments, the cells were subjected to rapid thawing
in a water bath at 37 °C.
Scanning electron microscopy
Cells were cultivated on glass coverslips, and after cul-
ture the cells were fixed in 2.5% glutaraldehyde, washed
in 0.1 M pH 7.4 phosphate buffer and post-fixed in 1%
osmium tetroxide followed by continuous dehydration
in ethanol (70%, 80%, 90%, 95% and 100%). Finally, the
cells were dehydrated to the dry critical point (Balzers
CPD 020). Subsequently, the samples were placed in a
metallic support for gold lining (“sputtering” Emitech
K550), and the analysis was performed in a scanning
electron microscope (ME Leo 435 VP).
Colourimetric assay (MTT)
The colourimetric assay (MTT) [38] consists of the reduc-
tion of the yellow-coloured 3-((4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) (MTT) compound by
the mitochondrial dehydrogenase enzyme (component
complex II of the Krebs cycle), which is present only in
viable cells. The experiment was conducted every 48 hours
for 12 days (288 hours) to analyse the proliferation of
rabbit amniotic membrane cells. On each day of the
experiment, approximately 1 × 103 cells were plated in 96-
well plates in a volume of 210 μl/well. Next, the culture
medium was removed, and 100 μl of new medium with
10 μl of MTT solution A (catalogue number V-13154; Life
Technologies, Carlsbad, CA, USA) was added. The solu-
tion was incubated for 4 hours at 37 °C, and after this
period 100 μl of Solution B (catalogue number V-13154;
Life Technologies, Carlsbad, CA, USA) was added, and
the cultures were maintained for an additional 4 hours at
37 °C. The analysis was then performed using a spectro-
photometer (MQuant–Bio Tek Instruments, VT, USA).
Flow cytometry
Immunophenotypic analysis was performed using flow cy-
tometry. For this, 1 × 105 cells/ml were trypsinized, centri-
fuged and fixed in 10% paraformaldehyde. The cells were
then incubated with primary antibodies (dilution 1:100)
for 30 minutes at 4 °C. After this period, the cells were in-
cubated with the secondary antibody (dilution 1:500) for
30 minutes at 4 °C. Finally, the cells were washed and ana-
lysed by a BD FACSariaIIu flow cytometer (Becton Dick-
inson, San Jose, CA, USA). Controls were performed
using unmarked cells exposed only to the non-specific
secondary antibody. For each sample, 10,000 events were
counted. The primary antibodies used were as follows:
Nanog (n-17, sc30331), Sox-2 (sc-17320), vimentin
(sc-73259), cytokeratin 18 (RGE53, sc-32329), Stro-1
(sc-47733), PCNA-3 (sc-46), β-tubulin (sc-47751), SSEA-4
(sc-59368), TRA-1-60 (sc-21705) and CD73 (sc-14684)
(all purchased from Santa Cruz Biotechnology, Inc.,
Europe); in addition to CD105 (ab53321; Abcam,
Cambridge, UK), CD117 (A4502; Dako Cytomation,
Carpinteria, CA, USA) and CD45 (MHCD4501; Invi-
trogen, Carlsbad, CA, USA). For nuclear antibodies
such as PCNA-3, Nanog and Sox-2 we added 0.1% of
triton (catalogue number 13-1315-05; LGC Biotecno-
logia) in order to permeabilize the cell membranes.
Total RNA isolation, cDNA synthesis and real-time reverse
transcription PCR
Total RNA was extracted from amniotic cells using the
Trizol manufacturer’s (catalogue number: 12183555
Invitrogen, Carlsbad, CA, USA) protocol, treated with
DNAseI (Thermo Scientific), and 1 μg was reverse-
transcribed to first-strand cDNA and subjected to
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quantitative real-time reverse transcription PCR (RT-
qPCR) according to Fratini et al. [39]. The primer se-
quences (Lin28a, c-myc, GAPDH) are presented in
Table 2. GAPDH was used as the reference gene. Rela-
tive expression levels of Lin28a and c-myc were calcu-
lated according to the Pfaffl model [40].
Statistical analysis was performed using GraphPad
Prisma software (version 6.01) with one-way ANOVA
followed by Tukey’s test for post-hoc comparison. p < 0.05
was considered statistically significant. The results were
presented as mean ± SEM.
Differentiation assays
For osteogenic and adipogenic differentiation, 1 × 104
cells were plated in 24-well plates. For osteogenic in-
duction 48 hours later, the medium was replaced with
osteogenic induction medium, which was comprised of
DMEM-HIGH supplemented with 7.5% FBS, 100 μM
ascorbic acid (Invitrogen), 100 mM β-glycerophosphate
(Sigma) and 0.1 mM dexamethasone (Decadron,
Schering-Plough, SP, Brazil). On day 21, cells were
washed with PBS and fixed with 4% paraformaldehyde.
Finally, the cells were stained by Von Kossa and Alizarin
Red stains. Adipogenic differentiation was induced by
adding DMEM-HIGH supplemented with 7.5% FBS,
10 μg/ml insulin (Sigma-Aldrich, St. Louis, MO, USA),
100 μM indomethacin (Sigma-Aldrich) and 1 mM dexa-
methasone (Decadron). After approximately 21 days, the
cells were washed with PBS, fixed with 4% paraformalde-
hyde for 15 minutes and stained with Oil Red. For chon-
drogenic differentiation, 1 × 106 cells were resuspended in
inductor medium (StemPro® Chondrogenesis Differenti-
ation Kit, catalogue number A 10071–01; GIBCO Invitro-
gen, Carlsbad, CA, USA) in a 15-ml conical polypropylene
tube and then centrifuged at 1200 rpm for 5 minutes. The
obtained cells were maintained at 37 °C in a humidified
atmosphere with 5% CO2, and the culture medium was
changed twice a week. After 21 days, cell aggregates were
embedded in paraffin and sectioned at 3–4 mm in an
automatic microtome (RM2165; LEICA). The slides were
then stained using Picrosirius and Masson’s trichrome.
Tumourigenicity assay
Nude mice was donated by the bioterium of FMVZ-
USP. To determine the tumourigenic potential, 1 × 106
cells were injected intramuscularly into the dorsal re-
gion of two nude mice. The mice were maintained
under specific pathogen-free conditions using an Iso-
rack and maintained for 8 weeks on sterile food and
water ad libitum in the bioterium of the School of
Veterinary Medicine and Animal Science, University of
Sao Paulo, Brazil. Every week, the animals were evalu-
ated clinically to identify possible tumour development.
After 8 weeks, the animals were euthanized using a
CO2 chamber following the principles of the bioethics
committee of FMVZ-USP. Samples from the kidney,
lung, liver, heart and spleen were collected and fixed in
4% paraformaldehyde. Tissues for histological examin-
ation were embedded in paraffin and sectioned at 5 μm,
stained with haematoxylin and eosin (HE) and analysed
using an Olympus light microscope (CX 31 RBSFA).
Results
Culture and morphology of amniotic membrane cells
For the primary cultures, three different culture media
with different glucose concentrations were tested:
MEM/ALPHA, DMEM-F12 (1:1) and DMEM-HIGH,
containing 5.6 mM, 17.6 mM and 25 mM glucose con-
centrations, respectively. After testing the three culture
media, all of which were supplemented with 15% FBS,
the most satisfactory results relating to increased cell ad-
hesion, growth, expansion, morphology and viability of
the rabbit amniotic membrane cells were obtained using
the DMEM-HIGH medium. After 24 hours of culture,
we were able to observe the first adherent cells in the
culture plates (Fig. 1a). Every 3 days, cells reached 80%
confluence, thereby generating expansion cultures
(Fig. 1b). Morphologically, cells had a fibroblast-like
shape with an elongated cytoplasm and central spherical
nucleus (Fig. 1c). In addition, the cultures remained
homogeneous after thawing, with a predominance of
cells that maintained satisfactory growth and fibroblast-
like morphologies. The cultures were maintained until
passage number 8, after which they were analysed by
Table 2 List of primer sequences used for RT-qPCR analysis in this study
Gene name Gene Direction per gene Accession number
Lin-28 homolog A Lin28a Forward 5´-GCACCAGAGTAAGCTGCACA XM_002716102.3
Reverse 5´-GGCGGACTTCTTGAAGGTGA
c-Myc v-myc avian myelocytomatosis
viral oncogene homolog
Forward 5´-TCTGCTCTCCTCCAACGAGT NM_001319575.1
Reverse 5´-TTGTTCTTCCTCAGAGTCGCT
Glyceraldehyde-3-phosphate
dehydrogenase
GAPDH Forward 5´-AAGGGTCATCATCTCAGCCC NM_001082253.1
Reverse 5´-TGCGTTGCTGACAATCTTGAG
RT-qPCR real-time reverse transcription PCR
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flow cytometry, during which we observed two different
cell populations with different sizes and granularities
(Fig. 1d).
Colorimetric assay (MTT)
During the evaluation of the cellular metabolism of pas-
sage 4 rabbit amniotic membrane cells grown in DMEM-
HIGH, we noted an increase in their metabolic activity
during early growth that lasted until the 4th day of the
trial and was followed by a decrease that was maintained
until the 6th day. The cells then continued to grow until
the 8th day, after which the growth rate decreased again
until the 12th day (Fig. 1e). In contrast, the metabolic ana-
lysis of passage 8 cells demonstrated a low growth rate
until the 6th day, which was followed by continued growth
until the 8th day and subsequently a steady decrease until
the 12th day (Fig. 1f).
Immunophenotyping
Similar results for nearly all markers were observed for
the flow cytometry analysis of rabbit amniotic cells dur-
ing passages 4 and 8.
The analysis of rabbit amniotic membrane cells dur-
ing passage 4 showed high levels of expression for cyto-
skeletal markers such as vimentin (58%), cytokeratin 18
(57.5%) and β-tubulin (26.2%). Mesenchymal markers
such as CD105 (40%) and Stro-1 (58.5%) were also
highly expressed, while CD73 (3.72%) was not. There
Fig. 1 Morphology and viability of rabbit amniotic-derived stem cells. a Cells cultured for 24 hours. Fibroblast-like cells adhered to the dish (arrows);
20× resolution. b Cells cultured for 72 hours. Intense contact between the cells (arrow) in high confluence (circle); 4× resolution. c Scanning electron
microscopy. Cells during the fourth passage maintain a fibroblast-like morphology during the passages (arrows) with an elongated cytoplasm and
central nucleus. d Flow cytometry analysis. Two distinct populations (circles) with different sizes and granularities. e, f Cellular metabolism testing during
passages 4 and 8, respectively, by the MTT colourimetric method. Increased viability of the passage 4 cells. FSC Forward Scatter, SSC Side Scatter, D.O
density optic
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was a low level of expression for the haematopoietic
stem cell precursor marker CD117 (18%) and for the
haematopoietic cell marker CD45 (7.29%). PCNA-3, a
marker of proliferation, was highly expressed (58%), as
were the pluripotency markers Nanog (70.1%), SSEA-4
(60.7%) and TRA-1 (52.7%), while there was a lower
level of expression for SOX-2 (14.2%) (Fig. 2).
At passage 8, the cells demonstrated high levels of the
cellular cytoskeleton markers vimentin (43.3%) and cyto-
keratin 18 (39.4%) but showed low levels of β-tubulin
Fig. 2 Immunophenotyping of rabbit amniotic cells at passage 4 analysed by flow cytometry. Significant levels of expression for cytoskeletal
markers (vimentin, cytokeratin, and β-tubulin) and mesenchymal cell markers (CD105 and Stro-1) and insignificant CD73 expression. Low levels of
expression for markers of haematopoietic stem cell precursors and haematopoietic cells (CD117 and CD45, respectively). Significant levels of
expression for markers of proliferation (PCNA-3) and pluripotency (Nanog, SSEA-4, Tra-1, and Sox-2). FITC fluorescein isothiocyanate
Borghesi et al. Stem Cell Research & Therapy  (2017) 8:27 Page 6 of 14
(13.6%) expression. Mesenchymal markers, including
CD73 (35.7%), CD105 (47.9%) and Stro-1 (40.1%), were
expressed at significant levels. CD117 was also highly
expressed during this passage (43.5%), unlike the haem-
atopoietic cell marker CD45 (0.57%) which was insignifi-
cantly detected. PCNA-3, a marker of proliferation, was
highly expressed (67.7%). Pluripotency markers such as
SSEA-4 (83.4%) and Sox-2 (33.8%) were also highly
expressed, in contrast to Nanog (0.72%) and Tra-1 (0.90%)
which did not show significant levels of expression
(Fig. 3).
RT-qPCR analysis
To explore the expression levels of pluripotency markers
c-myc and Lin28a in amniotic cells from different passages
(passages 4 and 8), RT-qPCR analysis was performed. The
results showed that the average level of c-myc was in-
creased in amniotic cells in passage 4 in relation to
passage 8 (Fig. 4). Lin28a had a detectable increase of
expression in amniotic cells isolated from passage 8
compared with passage 4 (Fig. 4).
Differentiation assays
After 21 days of induction, the amniotic membrane cells
showed the ability to differentiate into osteogenic, adipo-
genic and chondrogenic lineages. During adipogenic
differentiation, the fibroblast-like morphology of the cells
was replaced by cells with a globular cytoplasm and a
nucleus located at the periphery. Within the cytoplasm,
clusters of lipid vesicles were observed after staining with
Oil Red (Fig. 5a, b). During osteogenic differentiation, the
formation of a calcified extracellular matrix was observed
following staining by Von Kossa and Alizarin Red
(Fig. 5c, d). Regions with greater calcification could be
identified in the formed bone matrix. Differentiated
cells of the chondrogenic lineage were stained by Tri-
chrome Masson (Fig. 5e) and Picrosirius (Fig. 5f ). We
noted that the cells lost their previous fibroblast-like
morphology and adopted a more rounded shape, with
the appearance of regions similar to chondrocyte lacu-
nae and the presence of collagen fibres (Fig. 5e, f ).
Tumourigenicity assay
After 8 weeks, the nude mice, which were evaluated
clinically every week, did not show any signs of macro-
scopic or histopathological tumour formation. For fur-
ther analysis, the animals were euthanized, and the mice
receiving cell injections were analysed in detail (Fig. 6a).
Histopathologically, the kidneys, lungs, liver, heart and
spleen were analysed, showing normal structural charac-
teristics with no changes that were related to metastatic
tumour growth (Fig. 6b–f ).
Discussion
Recent studies have demonstrated a significant differen-
tiation capacity for stem cells derived from the amniotic
membrane, reaffirming the importance of studying the
morphology, cell development, differentiation ability, ap-
plicability and in-vivo treatment potential of these cells.
In the near future, it might be possible to extend the ap-
plicability of these cells to other diseases in addition to
the cell therapy applications in which they have already
been used [10, 41, 42]. Here, we investigated, for the first
time, the capacity of the rabbit amniotic membrane to
serve as a source of mesenchymal stem cells, with a
focus on establishing a protocol for culturing these cells
and characterizing these cells and their potential for dif-
ferentiation using immunophenotyping.
First, we identified the mid-point of pregnancy
(16 days) as the ideal pregnancy period for collecting
the amniotic membrane, which is similar to what has
been determined for rats [43]. Studies of the amniotic
membrane [44] and umbilical cord blood [45] from
early gestation and near term have suggested that cells
obtained from early gestation display a higher prolifera-
tive activity and a higher level of pluripotency and mes-
enchymal stem cell marker expression compared with
cells obtained late in gestation. It has been observed that
cells isolated from the amniotic membrane during mid-
gestation showed increased telomerase activity com-
pared with cells from late gestation [43]. However, these
studies also showed that, although there are differences
in the phenotypes of the cells based on their gestational
period, their immunomodulatory capacity remained un-
changed. Based on the data available from the scientific
literature and the ease with which the amniotic mem-
brane can be separated from the other membranes at
that time, the 16th day of gestation was used throughout
this study.
Moreover, amniotic membrane cells were isolated
using the explant method, which was the same as has
been used for rats [27] and dogs [3], in contrast to
other studies that used enzymatic digestion with trypsin
or collagenase to obtain a more homogeneous cell cul-
ture [46, 47]. According to the method of isolation of
cells from amniotic membrane, two cell types can be
obtained: epithelial cells can be isolated by trypsin di-
gestion, while fibroblast cells can be isolated by collage-
nase digestion [10]. However, our culture was produced
by the mechanical method (i.e. explants) and produced
a homogeneous culture containing only fibroblastic-like
cells. After defining the ideal isolation method, we next
optimized the culture medium, because there is limited
information available in the literature, particularly with
regard to rabbit cells. The media most commonly used
were ALFA-MEM [24], DMEM-F12 [7, 48] and, most
often, DMEM-HIGH [21, 49, 50]. We tested all three
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Fig. 3 Immunophenotyping of rabbit amniotic cells at passage 8 analysed by flow cytometry. Note the expression levels of cytoskeletal markers
(vimentin, cytokeratin and β-tubulin) and mesenchymal cell markers (CD73, CD105 and Stro-1). CD117 (a marker of haematopoietic stem cell
precursors) was highly expressed, while CD45 (a marker of haematopoietic cells) was not expressed. There were also significant levels of
expression for the proliferation marker PCNA-3 and the pluripotency markers SSEA-4 and Sox-2, while other pluripotency markers (Nanog and
TRA-1) were not expressed. FITC fluorescein isothiocyanate
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different media, which differed in their glucose concen-
trations, to investigate their influence on cell culture.
Glucose is the energy source for all cells; however,
high concentrations of glucose can affect proliferation,
differentiation and apoptosis, and can induce cell senes-
cence. The culture media tested had glucose concentra-
tions ranging from 5.6 to 25 mM [51]. Human bone
marrow stem cells were cultured using media with high
(25 mM), middle (11 mM) and low (5.6 mM) glucose con-
centrations [52] to assess cell proliferation, and the results
showed that when cells were exposed in a short-term cul-
ture (4 days), no effect was observed on cell proliferation.
In contrast, when exposed to long-term culture (4 weeks),
cells showed a slight but significant reduction in prolifera-
tion in the high-glucose medium. In our study, we ob-
served that both ALFA-MEM (5.6 mM) and DMEM-F12
(17.6 mM) produced less satisfactory growth compared
with DMEM-HIGH (25 mM). The DMEM-HIGH condi-
tion produced improved growth and proliferation in vitro
of rabbit amniotic membrane-derived stem cells, which
differed from the results of Li et al. [52]. It is noteworthy
that the first adherent cells with a fibroblast-like morph-
ology were observed in the first 24 hours of culture, which
has also been shown for rat amniotic cells [27].
After the cell culture was established, we performed a
cryopreservation assay. Cells were frozen and later
thawed for analysis, and similar fibroblast-like morph-
ologies and undifferentiated, high proliferative capaci-
ties were observed, which is similar to what has been
previously demonstrated for cells derived from cats [7].
Therefore, it is possible to create a cell bank for expan-
sion and to perform other future experiments such as
in-vitro and in-vivo tests.
In our cell viability studies, we observed using the
MTT assay that the cells during passage 4 showed an
initial increase in cell growth followed by a decrease be-
fore starting to grow again before a final decrease at the
end of the experiment. As shown in Fig. 1e and f, when
we used cells from passage 8 we observed a continuous
pattern of growth that was followed by a decrease until
the end of the experiment. These findings corroborate
previous data observed from cell culture, showing that
cells from passage 4 have an increased proliferation and
expansion capacity overall compared with cells from
advanced passages (passage 8); although the latter pas-
sage cells show continuous proliferation, it is delayed
relative to the early passages. This finding is in contrast
to other data from fibroblast cells obtained from the cat
amniotic membrane, which showed a continuous growth
throughout the entire experiment [7]. However, our
results are more similar to data obtained using cell
cultures [53]. In this previous study, the data showed an
initial wave of proliferation that was followed by a drop
in the proliferation rate, which ultimately rebounded at
the end of the experiment.
Subsequently, we analysed the immunophenotypes of
the cells during passages 4 and 8 by flow cytometry and
observed significant differences in the two passages in
the expression of various markers. We evaluated cyto-
skeletal and mesenchymal stem cell markers such as
vimentin and cytokeratin 18, which are intermediate fil-
aments, and β-tubulin, a microtubule membrane pro-
tein. Both vimentin and cytokeratin showed high levels
of expression in the amniotic stem cells, demonstrating
that our culture was heterogeneous in the cellular com-
position of mesenchymal and epithelial cells [47]. We
assessed markers for mesenchymal stem cells such as
CD73, CD105 and Stro-1, which also showed positive
staining in our cultures. The mesenchymal stem cell
marker CD105 had high expression during both pas-
sages 4 and 8 (40% and 47.9%, respectively). Similar re-
sults have been obtained with cells from humans [54].
However, Stro-1 showed a decreased expression during
passage 8 (40.1%) compared with passage 4 (58%),
which could be explained by the fact that one of the
characteristics of this marker is its loss of its expression
during subsequent passages [55]. However, the expres-
sion of CD73 during passage 4 was almost negligible
(3.72%), while during passage 8 there was a consider-
able increase in its expression (35.7%) [5, 7, 21]. The
Fig. 4 RT-qPCR analysis of amniotic cells (AMC) at passages 4 and 8
(P4 and P8). X axis, mRNA expression of the gene as the ratio of target
gene/GAPDH. ANOVA test followed by Tukey’s test for post-hoc
comparison were used for statistical analysis. Results presented as
mean ± SEM. Letters show statistically significant expression
differences: a, c-myc P4 vs Lin28a P4 (p < 0.0001); b, c-myc P4 vs c-myc
P8 (p < 0.01); c, c-myc P4 vs Lin28a P8 (p < 0.0001); d, Lin28a P4 vs
Lin28a P8 (p < 0.001); e, c-myc P8 vs Lin28a P8 (p < 0.001)
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rabbit amniotic cells were also positive for the haem-
atopoietic precursor cell marker CD117 and were nega-
tive for the haematopoietic marker CD45, which is in
agreement with previous studies [7, 27, 50].
PCNA-3, a marker of proliferating cells, was increased
by approximately 9.7% in passage 4 compared with pas-
sage 8. This is in agreement with our culture and MTT
analyses, which showed that the early passages were
more proliferative compared with later passages, which
is similar to what has been observed in the sheep amni-
otic membrane [44]. As demonstrated previously in
other species [11, 26, 48], rabbit amniotic stem cells
showed high levels of expression for pluripotency
markers such as SSEA-4 and Sox-2. In contrast, Nanog
and TRA-1 were highly expressed in the passage 4 cells
but were expressed at insignificant levels in passage 8
cells (2.73% and 2.76%, respectively). The Nanog is re-
sponsible for maintaining the pluripotency and the self-
renewal characteristics of embryonic stem cells, but the
factors that control Nanog expression remain unknown
[56]. TRA-1 is expressed on the surface of embryonic
cells and is downregulated during differentiation. TRA-1
is also similarly expressed in embryonic carcinoma cells
[57]. In addition, in both passages 4 and 8 the rabbit
Fig. 5 Differentiation assays (adipogenic, osteogenic and chondrogenic lineages) of cells isolated from the rabbit amniotic membrane. a, b
Adipogenic differentiation, as shown by Oil Red staining. Lipid vesicles in the cytoplasm of cells (arrows). In addition, the nucleus had moved to
the periphery of the cell. c, d Osteogenic differentiation as shown by Von Kossa and Alizarin Red staining, respectively. Note the presence of
calcified regions (arrows) in the extracellular matrix (EM). e, f Chondrogenic differentiation, as shown by Masson’s Trichrome and Picrosirius
staining, respectively. Cells showed a rounded shape with a globular nucleus (N) more strongly stained by Masson’s Trichrome which were
surround by an extensive matrix rich in collagen fibres (CF), similar to the morphology of chondroblasts. In addition, there was formation of
chondrocyte lacunae (CL)
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amniotic stem cells expressed the genes c-myc and
Lin28a in the RT-qPCR analysis, which are involved with
pluripotency. These proteins were studied previously in
amniotic stem cells obtained from the human and bo-
vine amnion [58, 59]. Therefore, we can conclude from
these results that the rabbit amniotic membrane cells
exhibit greater marked pluripotency characteristics in
passage 4 compared with passage 8. The ability of cells
to differentiate into specific lineages is one of the cri-
teria for their classification as stem cells. In our study,
we induced the cells through exposure to specific
media to differentiate into the adipogenic, osteogenic
and chondrogenic lineages. Rabbit amniotic stem cells
were able to differentiate into all three cell lineages,
which was expected based on similar results in cells
from the human [10, 21, 30, 60], horse [49], cat [7, 26]
and dog [5] amniotic membranes. In this study, the
time necessary for differentiation was 21 days, which
was the same as in the references cited previously.
However, this differs from stem cells derived from adult
tissue, where the differentiation time is shorter (14 days)
[61, 62]. The time needed for cellular differentiation is
directly related to the source of the cells being induced.
In general, adult tissue stem cells are committed to dif-
ferentiate into one specific cell type, and this is why a
shorter time is required for differentiation. Many stud-
ies have emerged to attempt to explain the effects of
high concentrations of glucose on cell differentiation.
In this context, high glucose levels result in the induc-
tion of osteogenic differentiation [63]. In that study, the
authors tested various concentrations ranging from 5.5
to 35 mM, and their results demonstrated that high
concentrations of glucose suppressed the bone
morphogenetic protein-2 (BMP-2) signalling pathway,
which plays an important role in the regulation of
osteogenic cell differentiation. The authors concluded
that high concentrations of glucose decrease the ability
of cells to differentiate along the osteogenic lineage.
However, in a similar study, two different concentrations
(17.6 and 25 mM) were tested, and the results showed that
the cells were able to differentiate along the osteogenic
lineage only when higher glucose concentrations were
used [52]. This latter finding is similar to our results, be-
cause we used a medium containing a high concentration
of glucose (DMEM-HIGH, 25 mM) for the induction of
osteogenic differentiation from rabbit amniotic membrane
cells. For adipogenic differentiation, it has been demon-
strated that high glucose concentrations increase both dif-
ferentiation along the adipogenic lineage and lipid
accumulation [64]. This is similar to our results where the
use of DMEM-HIGH (25 mM) produced satisfactory adi-
pogenic differentiation with the detection of fat vesicles
inside the cytoplasm. Expanded cells cultured in high glu-
cose concentrations prior to differentiation have been
shown to have a decreased ability for chondrogenic differ-
entiation [65, 66]. Conversely, Han et al. [67] showed that
a high glucose concentration (30 mM) had a dose-
dependent stimulatory effect on chondrogenesis. In this
study, the cells used to assess chondrogenic differentiation
were previously grown in DMEM-HIGH, which had the
highest glucose concentration of the media tested and was
similar to the medium described by Han et al. [67]. Using
this medium, we were able to obtain a satisfactory differ-
entiation of amniotic cells into chondrocytes.
In this field, studies have demonstrated that lysopho-
sphatidic acid (LPA), an extracellular lipid molecule, is
Fig. 6 Tumorigenic analysis of rabbit amniotic membrane cells injections into nude mice. a Macroscopically, after 8 weeks of injection there was no
tumour formation. Histopathologic analysis of the b kidney, c lung, d liver, e heart and f spleen. In all samples analysed, there was no evidence of
tumour formation, and the organs were observed to have retained normal histological features. GL glomerulus, PCT proximal convoluted tubule, A
alveolus, CV lobular central vein
Borghesi et al. Stem Cell Research & Therapy  (2017) 8:27 Page 11 of 14
involved with the maintenance of cell survival and prolif-
eration in vitro. Originally produced in reproductive tis-
sues, LPA controls the ovarian cycle and pregnancy,
acting in the uterus, ovary, placenta and foetal membranes
[68]. In addition, LPA expression is higher in amniotic
membrane than in placental tissues [69]. Kim et al. [70]
reported that when stimulated with LPA the amniotic
membrane cells increased cell proliferation, similar to
what is known for neuronal and blood stem cells [71, 72].
Following the isolation, characterization and differenti-
ation of rabbit amniotic cells, which are prerequisites to
define a stem cell, we conducted a tumourigenic potential
assay to evaluate the safety of these cells for use in regen-
erative medicine applications. The rabbit amniotic cells
from both passages 4 and 8, when injected into nude mice,
did not show metastatic potential. This result confirms
previous descriptions regarding the safety of amniotic
stem cells [7, 53].
Conclusion
We were able to obtain a multipotent mesenchymal stem
cell lineage from the rabbit amniotic membrane. These
cells expressed specific markers for mesenchymal stem
cells and pluripotency, did not express markers of haem-
atopoietic cells and were able to differentiate into different
mesenchymal cell lineages. In addition, the analysis of
tumourigenic potential showed that rabbit amniotic stem
cells are safe for use in future therapies, as has been previ-
ously demonstrated for other species. These cells also ex-
hibit a high level of expandability and the capacity for
proliferation in vitro, which are essential characteristics
for storage in cell banks.
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